Hald J K, Eldevik O P, Brunberg J A, Chandler W F
Department of Radiology, University of Michigan Hospitals, Ann Arbor.
Acta Radiol. 1994 Nov;35(6):520-5.
To evaluate the efficacy of i.v. contrast medium administration in MR imaging at 1.5 T in patients with craniopharyngiomas, MR studies of 10 men and 6 women with pathologically proven craniopharyngiomas were made. The MR images were obtained as 3- to 5-mm-thick coronal (n = 13) or axial (n = 3) Tl-weighted images (T1WI) prior to and following i.v. Gd-DTPA administration. Proton density- (PD) and T2-weighted images (T2WI) were also obtained. Conspicuity of tumor margins, cystic versus solid components, size, location and effect upon adjacent structures were separately characterized in all imaging sequences. In 6 patients contrast medium-enhanced T1WI. PD and T2WI demonstrated cystic tumor components not seen on unenhanced T1WI. There were significant differences (p < 0.004) on 2-tailed Student's t-test comparing tumor conspicuity on contrast medium-enhanced T1WI with unenhanced T1WI, PD and T2WI. Optimal tumor delineation on MR imaging of patients with craniopharyngiomas justifies the use of i.v. contrast medium.
为评估静脉注射造影剂在1.5T磁共振成像中对颅咽管瘤患者的效果,对10名男性和6名女性经病理证实患有颅咽管瘤的患者进行了磁共振研究。在静脉注射钆喷酸葡胺(Gd-DTPA)之前和之后,获取3至5毫米厚的冠状面(n = 13)或横断面(n = 3)T1加权图像(T1WI)的磁共振图像。还获取了质子密度(PD)和T2加权图像(T2WI)。在所有成像序列中分别对肿瘤边缘的清晰度、囊性与实性成分、大小、位置以及对相邻结构的影响进行了特征描述。在6名患者中,造影剂增强的T1WI、PD和T2WI显示出未增强T1WI上未见的囊性肿瘤成分。在双尾学生t检验中,对比造影剂增强的T1WI与未增强的T1WI、PD和T2WI上的肿瘤清晰度存在显著差异(p < 0.004)。颅咽管瘤患者磁共振成像上的最佳肿瘤描绘证明了静脉注射造影剂的使用合理性。